Cargando…

Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine

Variants of SARS-CoV-2 lineages including the most recently circulated Omicron, and previous pandemic B.1.351, B.1.1.7, which have been public concerns, contain a N501Y mutation located in the spike receptor binding domain. However, the potential interactions with host cells linking N501Y mutation t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazybay, Bexultan, Ahmad, Ashfaq, Mu, Chenglin, Mengdesh, Diana, Xie, Yingqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677628/ https://www.ncbi.nlm.nih.gov/pubmed/34929375 http://dx.doi.org/10.1016/j.tmaid.2021.102242

Ejemplares similares

Urgency of COVID-19 vaccination in adolescents: Androgen and estrogen receptors view
por: Kazybay, Bexultan, et al.
Publicado: (2022)

Re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
por: Kazybay, Bexultan, et al.
Publicado: (2021)

Network pharmacology and experimental investigation of Rhizoma polygonati extract targeted kinase with herbzyme activity for potent drug delivery
por: Xie, Yingqiu, et al.
Publicado: (2021)

Nano-evolution and protein-based enzymatic evolution predicts novel types of natural product nanozymes of traditional Chinese medicine: cases of herbzymes of Taishan-Huangjing (Rhizoma polygonati) and Goji (Lycium chinense)
por: Nazarbek, Guldan, et al.
Publicado: (2021)

Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis
por: Saeed, Aamir, et al.
Publicado: (2022)

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies
por: Alrouji, Mohammed, et al.
Publicado: (2023)

Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
por: Sarsenova, Madina, et al.
Publicado: (2022)

Network Pharmacology with Experimental Investigation of the Mechanisms of Rhizoma Polygonati against Prostate Cancer with Additional Herbzymatic Activity
por: Kazybay, Bexultan, et al.
Publicado: (2022)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

In Silico screening for functional candidates amongst hypothetical proteins
por: Desler, Claus, et al.
Publicado: (2009)

Honghua extract mediated potent inhibition of COVID-19 host cell pathways
por: Madikyzy, Malika, et al.
Publicado: (2022)

In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
por: Çubuk, Hasan, et al.
Publicado: (2022)

Hypothetical in silico model of the early-stage intermediate in protein folding
por: Kalinowska, Barbara, et al.
Publicado: (2013)

Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Identification of a Fungi-Specific Lineage of Protein Kinases Closely Related to Tyrosine Kinases
por: Zhao, Zhongtao, et al.
Publicado: (2014)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
por: Martin, Darren P., et al.
Publicado: (2021)

In silico design and screening of hypothetical MOF-74 analogs and their experimental synthesis
por: Witman, Matthew, et al.
Publicado: (2016)

In silico structural and functional characterization of hypothetical proteins from Monkeypox virus
por: Gupta, Kajal
Publicado: (2023)

Novel Anthraquinone-based Derivatives as Potent Inhibitors for Receptor Tyrosine Kinases
por: Stasevych, M., et al.
Publicado: (2015)

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
por: Hashimoto, Sachiko, et al.
Publicado: (2002)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
por: Nava, Maria G., et al.
Publicado: (2022)

Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia
por: Natarajan, Aparna, et al.
Publicado: (2019)

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
por: Ananthula, Hari Krishna, et al.
Publicado: (2018)

Preparing for R501
Publicado: (1977)

Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage)
por: Rabie, Amgad M., et al.
Publicado: (2023)

Año 501 : la conquista continúa /
por: Chomsky, Noam
Publicado: (1993)

Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses
por: Jeong, Bo-Seong, et al.
Publicado: (2022)

Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
por: Huang, Fangmin, et al.
Publicado: (2023)

In Silico Structural and Functional Annotation of Hypothetical Proteins of Vibrio cholerae O139
por: Islam, Md. Saiful, et al.
Publicado: (2015)

Statistical dictionaries for hypothetical in silico model of the early-stage intermediate in protein folding
por: Kalinowska, Barbara, et al.
Publicado: (2015)

Correction: In silico structural and functional characterization of hypothetical proteins from Monkeypox virus
por: Gupta, Kajal
Publicado: (2023)

Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
por: Kim, Hyung-Gu, et al.
Publicado: (2013)

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
por: Krchniakova, Maria, et al.
Publicado: (2020)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses
por: Jeong, Bo-Seong, et al.
Publicado: (2022)

Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing
por: Wang, Zichen, et al.
Publicado: (2020)

Dictionary of 501 Spanish Verbs
por: Kendris, C.
Publicado: (1971)

Clipper 5.01 avanzado /
por: Ramalho, José A.
Publicado: (1992)

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
por: Mohamed, Eslam A. R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vfaa0s6vlt9um5gu22kkutle9u